Related Experiment Video
Updated: Jun 29, 2026
08:19
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
A role for IFN-lambda1 in multiple myeloma B cell growth.
A J Novak1, D M Grote, S C Ziesmer
1Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA.
Leukemia
|October 3, 2008
Summary
Interferon (IFN)-lambda1 promotes multiple myeloma (MM) cell growth and survival. This study reveals that MM cells bind IFN-lambda1, which enhances their proliferation and protects them from drug-induced death, suggesting therapeutic potential.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Multiple myeloma (MM) is a plasma cell malignancy with incompletely understood growth mechanisms.
- Cytokines like IL-6 are known to promote MM cell proliferation.
- Interferon (IFN)-lambda1 is a cytokine with known roles in viral immunity.
Purpose of the Study:
- To investigate the role and significance of IFN-lambda1 in multiple myeloma cell biology.
- To determine if IFN-lambda1 influences MM cell growth, survival, and signaling pathways.
Main Methods:
- Binding assays to assess myeloma cell interaction with soluble IFN-lambda1.
- Cell proliferation assays to measure the effect of IFN-lambda1 on MM cell growth.
- Assessment of cell death in response to dexamethasone with and without IFN-lambda1.
- Western blot analysis to detect phosphorylation of key signaling proteins (STAT1, STAT3, Erk).
Main Results:
- Myeloma cells demonstrate binding to soluble IFN-lambda1.
- IFN-lambda1 significantly induces myeloma cell proliferation.
- IFN-lambda1 confers protection against dexamethasone-induced myeloma cell death.
- IFN-lambda1 triggers the phosphorylation of STAT1, STAT3, and Erk signaling pathways.
Conclusions:
- IFN-lambda1 plays a regulatory role in multiple myeloma cell biology.
- IFN-lambda1 promotes MM cell growth and survival.
- IFN-lambda1 signaling pathways (STAT1, STAT3, Erk) are activated in myeloma cells.
- IFN-lambda1 represents a potential therapeutic target for multiple myeloma treatment.
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:26NF-kB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...